Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
7.08
+0.11 (1.58%)
At close: Aug 19, 2026, 4:00 PM EDT
7.04
-0.04 (-0.64%)
After-hours: Aug 19, 2026, 7:30 PM EDT

Harvard Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
323092228115288
Market Cap Growth
36.57%-67.60%-59.70%97.92%-59.89%72.07%
Enterprise Value
7066133268167336
Last Close Price
7.086.6921.1053.5027.7070.50
Forward PE
39.337.8717.5823.2617.8722.03
PS Ratio
0.370.340.982.041.022.42
PB Ratio
4.342.171.453.131.603.45
P/FCF Ratio
-5.45-18.66-4294.24
P/OCF Ratio
49.514.4363.9116.28100.17227.98
PEG Ratio
-1.031.031.031.031.03
EV/Sales Ratio
0.800.761.422.391.482.83
EV/EBITDA Ratio
9.498.8454.6428.2770.1529.73
EV/EBIT Ratio
35.4843.91-107.55-91.12
EV/FCF Ratio
-12.02-21.92-5018.20
Debt / Equity Ratio
5.963.220.700.590.750.68
Debt / EBITDA Ratio
4.524.539.673.7012.094.24
Debt / FCF Ratio
-8.09-3.51-850.15
Net Debt / Equity Ratio
5.082.600.640.480.690.59
Net Debt / EBITDA Ratio
5.124.7916.593.7120.874.34
Net Debt / FCF Ratio
-33.696.52-33.632.88-113.55733.42
Asset Turnover
1.120.840.710.790.740.75
Inventory Turnover
1.651.661.641.791.892.06
Quick Ratio
0.851.120.350.770.911.17
Current Ratio
1.872.200.821.852.202.43
Return on Equity (ROE)
-89.95%-147.13%-18.19%-4.70%-12.23%-0.36%
Return on Assets (ROA)
1.57%0.91%-2.23%1.10%-2.11%1.45%
Return on Capital Employed (ROCE)
3.80%2.60%-6.60%2.30%-4.30%2.70%
Earnings Yield
-32.30%-190.17%-13.48%-1.49%-8.25%-0.10%
FCF Yield
-3.47%18.35%-1.31%5.36%-0.38%0.02%
Buyback Yield / Dilution
-1.81%-1.96%-2.64%-2.43%-2.65%-4.41%
SEC Filings: 10-K · 10-Q